ACTA NEUROPHARMACOLOGICA››2011,Vol. 1››Issue (5): 1-7.
LI Dong-wei，DOU De-qiang
Online:2011-10-26Published:2013-03-24Contact:窦德强，男，教授，博士研究生导师；Tel：+86-0411-87406497，E-mail：doudeqiang7003@yahoo.com.cnAbout author:李东薇，女，硕士研究生；研究方向：中药药效物质基础；E-mail：wei-5599@163.comCLC Number:
LI Dong-wei, DOU De-qiang. Protective Effect of PPT and Ginsenoside-Re in MPP+-treated SH-SY5Y Cells[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(5): 1-7.
| [1]Steven Karceski. Parkinson disease and polyneuropathy[J]. Neurology, 2011, 77(22):e132-e134. [2]Halliday GM, Del Tredici K, Braak H. Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease [J]. J Neural Transm (Suppl), 2006, 70: 99-103. [3]Guo Hua, Song Junping. Latest research progress at home and abroad of pathogenesis of Parkinson’s disease[J]. Occupy and Health, 2012, 28(4):490-492. [4] Symptomatic pharmacological therapy in Parkinson’s disease [M]//Royal College of Physicians. Parkinson’s disease: national clinical guideline for diagnosis and management in primary and secondary care. London: the Lavenham Press Ltd, Sudbury, Suffolk, 2006: 59-97. [5] Mark R.Cookson. The biochemistry of Parkinson’s disease[J]. Annn Rev Biochem, 2005, 74:29-52. [6]张登本．神农本草经卷二[M]//全注全译神农本草经．第一版．北京：新世界出版社，2009：17-18. [7]吴崑著，宋白杨校注．中风门第一[M]//医方考脉语．第一版．北京：中国医药科技出版社，2012：10. [8]危亦林著，金芬芳校注．卷第十三风科[M]//世医得效方．第一版．北京：中国医药科技出版社，2011：256-257. [9]危亦林著，戴铭校注．卷第十三风科[M]//世医得效方．第二版．北京：中国医药科技出版社，2009：542. [10] 孙一奎著，周琦校注. 赤水玄珠[M]//赤水玄珠．第一版．北京：中国医药科技出版社，2011：495. [11] 解洪荣，张玉花，李雪松，等．MPTP/MPP+诱导的帕金森病实验模型的研究进展[J]．医学综述，2011，17（5）：669-672. [12] Celine A. Beamer, David M. Shepherd .Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng[J].J Neuroimmune Pharmacol, 2012, 7(2):465-476. [13] Zhang Xu, Yu Li, Bi Hong-tao, et al. Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C.A. Meyer[J]. Carbohydrate Polymer, 2009, 77(3):544-552. [14] Wang Jun, Xu Hua-min, Yang Hai-dong, et al. Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins[J]. Neurochem Int, 2009, 54(1):43-48. [15] Chen Li-min, Zhou Xiao-mian, Cao Ying-lin, et al. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats[J]. J Asian Nat Prod Res, 2008, 10 (5-6):439-445. [16] Xu Bei-Bei, He Wen-fei, Lu Jin-cai, et al. Effects of ginsenoside Re on the levels of brain monoamines transmitters and serum corticosterone in water immersion-restraint rats[J].Natural product research development, 2009, 21(5):752-756, 786. [17] Liu Qian, Kou Jun-ping, Yu Bo-yang. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation[J]. Neurochem Int, 2011,58(1):119-125. [18] Hu Sheng-quan, Han Ren-wen, Shinghung Mak, et al. Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells[J].J Ethnopharmacol, 2011, 135(1):34-42. |
| [1] | XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8. |
| [2] | SUN Li-cong, ZHANG Dan-shen.Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37. |
| [3] | WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si.Current Situation and Prospect of Alzeimer’s Disease Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42. |
| [4] | ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia.Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64. |
| [5] | HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64. |
| [6] | ZHANG Hao-ting, SONG Gui-qin, CUI Ruo-tong, HAO Min, WANG Wen-dong.Mining Target Genes of Alzheimer’s Disease Associated with Biological Clock by Bioinformatics Analysis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 1-7. |
| [7] | GAO Yun-xia, ZHANG Yuan-yuan.The Role of Endoplasmic Reticulum Stress in Senile Macular Degeneration[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 21-26. |
| [8] | YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong.Research Progress in Drug Treatment of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53. |
| [9] | MO Cui-ying, LUO Guo-ping.Influence of Nimergoline Combined with Trasylin and Psychotherapy for Depression in Patients with Post-stroke Depression[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 7-10. |
| [10] | LIU Shan, LI Wei.Research Progress on Pharmacological Effects of L-theanine[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 24-32. |
| [11] | ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46. |
| [12] | YANG-Lin，AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64. |
| [13] | ZHANG Shuai，AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20. |
| [14] | 王奇.Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease[J]. Acta Neuropharmacologica, 2018, 8(5): 71-72. |
| [15] | CUI Su-ying, SONG Jin-zhi, CUI Xiang-yu, HU Xiao, DING Hui, YE Hui, ZHANG Yong-he.Intracerebroventricular Streptozocin-induced Alzheimer’s Disease-like Sleep Disorders: Role of the GABAergic System in the Parabrachial Complex[J]. Acta Neuropharmacologica, 2018, 8(5): 96-97. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
